a hrefhttps:www.fiercepharma.commanufacturingjubilant-hollisterstier-gets-fda-warning-letter-quality-control-problems hreflangenJubilant HollisterStier gets FDA warning letter for quality control problemsa

FIERCE PHARMAneutralhealth2026-06-25 12:11:46 UTC
AdYour ad here[email protected]

Jubilant HollisterStier, a CDMO unit of Indias Jubilant Pharmova,nbspearned an FDA warning letter after inspectors found its Montreal production plant lacked appropriate quality control systems.

Read the full story at Fierce Pharma ↗
AdYour ad here[email protected]